Dong-Hoon Jin

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

African American

Benign Prostatic Hyperplasia

Epidermal Growth Factor Receptor

Top Venues

Journal of cellular and molecular medicine

Cancer immunology research

Medical oncology (Northwood, London, England)

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine (2024)
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine 28 (3) (2024)
Dong-In Koh, Minki Lee, Yoon Sun Park, Jae-Sik Shin, Joseph Kim, Yea Seong Ryu, Jun Hyung Lee, Seunggeon Bae, Mi So Lee, Jun Ki Hong, Hong Rae Jeong, Mingee Choi, Seung-Woo Hong, Dong Kwan Kim, Hyun-Kyung Lee, Bomi Kim, Yoo Sang Yoon, Dong-Hoon Jin
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy. Cancer immunology research 12 (4) (2024)
Dong-In Koh, Minki Lee, Yoon Sun Park, Jae-Sik Shin, Joseph Kim, Yea Seong Ryu, Jun Hyung Lee, Seunggeon Bae, Mi So Lee, Jun Ki Hong, Hong Rae Jeong, Mingee Choi, Seung-Woo Hong, Dong Kwan Kim, Hyun-Kyung Lee, Bomi Kim, Yoo Sang Yoon, Dong-Hoon Jin
The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy. Cancer immunology research 12 (4) (2024)
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine 28 (3) (2024)
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine 28 (3) (2024)
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine 28 (3) (2024)
Hyeseon Yun, Hong-Rae Jeong, Do Yeon Kim, Ji-Eun You, Ji-U Lee, Dong-Hee Kang, Dong-In Koh, Yea Seong Ryu, SeungGeon Bae, Dong-Hoon Jin
Degradation of AZGP1 suppresses apoptosis and facilitates cholangiocarcinoma tumorigenesis via TRIM25. Journal of cellular and molecular medicine 28 (3) (2024)
Dong-In Koh, Minki Lee, Yoon Sun Park, Jae-Sik Shin, Joseph Kim, Yea Seong Ryu, Jun Hyung Lee, Seunggeon Bae, Mi So Lee, Jun Ki Hong, Hong Rae Jeong, Mingee Choi, Seung-Woo Hong, Dong Kwan Kim, Hyun-Kyung Lee, Bomi Kim, Yoo Sang Yoon, Dong-Hoon Jin
The immune suppressor IGSF1 as a potential target for cancer immunotherapy. Cancer immunology research (2024)
Joseph Kim, Dong-In Koh, Minki Lee, Yoon Sun Park, Seung-Woo Hong, Jae-Sik Shin, Mi So Lee, Min-Hwa Kim, Jun Hyung Lee, Joonyee Jeong, Seunggeon Bae, Jun Ki Hong, Hong-Rae Jeong, Yea Seong Ryu, Seung-Mi Kim, Mingee Choi, Hyojin Kim, Hyun Ryu, Sun-Chul Hur, Junho Park, Dae Young Hur, Dong-Hoon Jin
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy. Cell death and differentiation (2023)
Yoon Sun Park, Joseph Kim, Yea Seong Ryu, Jai-Hee Moon, Yu Jin Shin, Jeong Hee Kim, Seung-Woo Hong, Soo-A Jung, Seul Lee, Seung-Mi Kim, Dae Hee Lee, Do Yeon Kim, Hyeseon Yun, Ji-Eun You, Dong Il Yoon, Chul Hee Kim, Dong-In Koh, Dong-Hoon Jin
Mutant PIK3CA as a negative predictive biomarker for treatment with a highly selective PIM1 inhibitor in human colon cancer. Cancer biology & therapy 24 (1) (2023)
Hyeseon Yun, Ji-Eun You, Jun Ki Hong, Do Yeon Kim, Ji-U Lee, Dong-Hee Kang, Yea Seong Ryu, Dong-In Koh, Dong-Hoon Jin
TCOF1 promotes the colorectal cancer progression by stabilizing β-catenin. Medical oncology (Northwood, London, England) 40 (12) (2023)
Seung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, Soo-A Jung, Dong-In Koh, Yeaseong Ryu, Yoon Sun Park, Do Yeon Kim, Sang-Soo Park, Jun Ki Hong, Eun Ho Kim, Mi Jin Kim, Hong-Rae Jeong, In Hwan Bae, Young-Gil Ahn, Kwee Hyun Suh, Ig-Jun Cho, Jong-Soon Kang, Yong Sang Hong, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells. Investigational new drugs 38 (6) (2020)